Pfizer Inc. (PFE)

USD 25.89

(-2.04%)

Total Assets Summary of Pfizer Inc.

  • Pfizer Inc.'s latest annual total assets in 2023 was 226.5 Billion USD , up 14.86% from previous year.
  • Pfizer Inc.'s latest quarterly total assets in 2024 Q2 was 216.19 Billion USD , down -2.22% from previous quarter.
  • Pfizer Inc. reported annual total assets of 197.2 Billion USD in 2022, up 8.67% from previous year.
  • Pfizer Inc. reported annual total assets of 181.47 Billion USD in 2021, up 17.67% from previous year.
  • Pfizer Inc. reported quarterly total assets of 206.81 Billion USD for 2024 Q3, up 1.52% from previous quarter.
  • Pfizer Inc. reported quarterly total assets of 221.09 Billion USD for 2024 Q1, down -2.39% from previous quarter.

Annual Total Assets Chart of Pfizer Inc. (2023 - 1989)

Historical Annual Total Assets of Pfizer Inc. (2023 - 1989)

Year Total Assets Total Assets Growth
2023 226.5 Billion USD 14.86%
2022 197.2 Billion USD 8.67%
2021 181.47 Billion USD 17.67%
2020 154.22 Billion USD -7.92%
2019 167.48 Billion USD 5.06%
2018 159.42 Billion USD -7.2%
2017 171.79 Billion USD 0.11%
2016 171.61 Billion USD 2.48%
2015 167.46 Billion USD -1.07%
2014 169.27 Billion USD -1.64%
2013 172.1 Billion USD -7.37%
2012 185.79 Billion USD -1.17%
2011 188 Billion USD -3.6%
2010 195.01 Billion USD -8.42%
2009 212.94 Billion USD 91.59%
2008 111.14 Billion USD -3.57%
2007 115.26 Billion USD 0.38%
2006 114.83 Billion USD -2.32%
2005 117.56 Billion USD -4.95%
2004 123.68 Billion USD 5.92%
2003 116.77 Billion USD 151.91%
2002 46.35 Billion USD 18.4%
2001 39.15 Billion USD 16.84%
2000 33.51 Billion USD 62.88%
1999 20.57 Billion USD 12.41%
1998 18.3 Billion USD 19.34%
1997 15.33 Billion USD 4.56%
1996 14.66 Billion USD 15.22%
1995 12.72 Billion USD 14.69%
1994 11.09 Billion USD 18.94%
1993 9.33 Billion USD -2.7%
1992 9.59 Billion USD -0.46%
1991 9.63 Billion USD 6.44%
1990 9.05 Billion USD 8.74%
1989 8.32 Billion USD 9.0%

Peer Total Assets Comparison of Pfizer Inc.

Name Total Assets Total Assets Difference
AbbVie Inc. 134.71 Billion USD -68.138%
Bristol-Myers Squibb Company 95.15 Billion USD -138.024%
Bristol-Myers Squibb Company Ce 95.15 Billion USD -138.024%
Johnson & Johnson 167.55 Billion USD -35.178%
Eli Lilly and Company 64 Billion USD -253.873%
Merck & Co., Inc. 106.67 Billion USD -112.328%
Novartis AG 99.94 Billion USD -126.626%
Organon & Co. 12.05 Billion USD -1778.429%